LITOXETINE BENZOATE
UNII 3N6AFA37Y3

Substance Identification & Data

This profile provides standardized clinical and technical data for Litoxetine Benzoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3N6AFA37Y3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 125335-37-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3N6AFA37Y3

CAS Registry Number

125335-37-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LITOXETINE BENZOATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C16H19NO.C7H6O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

XALIHSKERZFMMK-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C224345

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

169490723

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1c2ccccc2cc(COC3CCNCC3)c1.c1cccc(c1)C(O)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Litoxetine Benzoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.